Price
$30.78
Decreased by -0.06%
Dollar volume (20D)
27.83 M
ADR%
7.24
Earnings report date
Feb 20, 2025
Shares float
54.37 M
Shares short
5.74 M [10.56%]
Shares outstanding
94.69 M
Market cap
2.92 B
Beta
0.15
Price/earnings
N/A
20D range
27.00 35.50
50D range
27.00 38.12
200D range
14.90 38.12

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy.

The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials.

In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders.

Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 7, 24 -0.36
Increased by +12.20%
-0.37
Increased by +2.70%
Aug 8, 24 -0.34
Increased by 0.00%
-0.34
May 9, 24 -0.33
Increased by +8.33%
-0.39
Increased by +15.38%
Feb 22, 24 -0.47
Decreased by -51.61%
-0.43
Decreased by -9.30%
Nov 9, 23 -0.41
Decreased by -20.59%
-0.40
Decreased by -2.50%
Aug 10, 23 -0.34
Decreased by -6.25%
-0.40
Increased by +15.00%
May 11, 23 -0.36
Decreased by -20.00%
-0.36
Feb 23, 23 -0.31
Decreased by -19.23%
-0.34
Increased by +8.82%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 24 N/A
Decreased by N/A%
-34.13 M
Decreased by -32.73%
- -
Jun 30, 24 0.00
Decreased by N/A%
-31.50 M
Decreased by -46.71%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-28.52 M
Decreased by -44.57%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 2.25 M
Increased by +N/A%
-30.14 M
Decreased by -79.95%
Decreased by -1.34 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-25.71 M
Decreased by -53.66%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-21.47 M
Decreased by -37.24%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-19.73 M
Decreased by -36.13%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by N/A%
-16.75 M
Decreased by -31.94%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY